Top Markets
#1 Helium Helium +54.24%
#2 TENDIES TENDIES +42.67%
#3 Pons Pons +31.17%
#4 UnifAI Network UnifAI Network +19.26%
#5 Seeker Seeker +18.62%
#6 Songbird Songbird +12.62%
#7 Lista DAO Lista DAO +11.02%
#8 OSK OSK +10.04%
#9 DAPPOS DAPPOS +9.30%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.97%
Coin of the day
Helium Helium
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Peringkat dalam Saham #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Harga Saham
$14.66
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$839.37M
Perubahan (1 hari)
-2.67%
Perubahan (1 tahun)
557.32%
Negara
US
Perdagangan Climb Bio, Inc. (CLYM)

Kategori

Healthcare
Riwayat harga saham Climb Bio, Inc. (CLYM)
Harga penutupan tertinggi: $15.73 pada 2026-08-01

Harga penutupan terendah: $7.23 pada 2024-09-01
Riwayat harga saham Climb Bio, Inc. dari 2024 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH